RUO‘ZENLog in
Stocks › Healthcare › AMRX

Amneal Pharmaceuticals stockAMRX

Amneal Pharmaceuticals Inc · Nasdaq
$19.45
−2.51% on the day
close Nov 5, 2026
What is happening with the stock

Amneal Pharmaceuticals trades at $19.45, 10.3% below its 52-week high (Nov 2, 2026). The price is above its 50- and 200-day averages, i.e. in an uptrend. +54.4% year to date, +66.4% over 12 months (S&P 500 over the same period: +8.8%). Next earnings report: Feb 26, 2027.

Closing price, 6 monthsdetailed chart in the terminal
11.5716.7421.9052-week high 21.68May 8, 2026Nov 5, 2026
Reported figurestrailing 12 months
🔒 Sector comparison, estimates and ratings are in the terminal

Ratings, candles, signals and the screener for AMRX — after you log in

Open the terminal
From 52-week high−10.3%
High21.68 Nov 2, 2026
vs 50-day avg+0.8%
vs 200-day avg+22.5%
Year to date+54.4%
12 months+66.4%
P/E18.7
Dividend yieldnone
EarningsFeb 26
Market cap$6.8B
Chart patternflat base
Exchange · sinceNasdaq · 1995

Frequently asked questions about Amneal Pharmaceuticals

What is the Amneal Pharmaceuticals stock price?

At the close on Nov 5, 2026: $19.45 (−2.51% on the day). 52-week high: $21.68 on Nov 2, 2026. During the session the price is updated with a 15-minute delay, after the close with the day's final figures.

When does Amneal Pharmaceuticals report earnings?

The next quarterly report is on Feb 26, 2027. Last quarter, earnings per share changed +53% year over year, revenue +10%.

Does Amneal Pharmaceuticals pay dividends?

No, Amneal Pharmaceuticals does not pay dividends.

Where does Amneal Pharmaceuticals trade and how to buy it?

Ticker AMRX, exchange Nasdaq, listed since 1995. You can buy it through a broker with access to US exchanges.

Should I buy Amneal Pharmaceuticals now?

We do not give buy or sell advice. Ratings, the detailed chart and signals for AMRX are in the terminal after you log in.

Similar stocks

More on AMRX

Included in lists